Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adhesion of New vs Aged Fentanyl Transdermal System vs Duragesic
NCT02608320Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2015
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of fentanyl in pain (2 cohorts), sponsored by Janssen Pharmaceutical. Primary endpoint: Cumulative Adhesion Percentage at 72 hours. Started Nov 2015; status: completed.
02
Drugs
fentanyl
03
Conditions
pain
Beyond the preview
Go deeper on NCT02608320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608320.